Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryArtificial IntelligenceAI Drug Discovery

PUBLISHER: Grand View Research | PRODUCT CODE: 1941434

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1941434

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Artificial Intelligence In Drug Discovery Market Summary

The global artificial intelligence in drug discovery market size was estimated at USD 2.35 billion in 2025 and is projected to reach USD 13.77 billion by 2033, growing at a CAGR of 24.8% from 2026 to 2033. The rising demand for cost-effective drug development, the increasing number of clinical trials in drug repurposing, and the growing prevalence of chronic diseases are significant factors contributing to market growth.

In addition, the growing focus on precision medicine and targeted drug development, as well as improvements in computing power and cloud infrastructure, are other factors fueling market growth. The rising demand for cost-effective drug development strategies substantially drives the growth of artificial intelligence (AI) in the drug discovery industry. According to an article published in the Frontiers in Pharmacology Journal in October 2025, Traditional drug discovery involves lengthy timelines, often exceeding a decade, and costs frequently exceed USD 2 billion per drug. AI in drug discovery and repurposing offers a strategy to bypass early-stage safety testing by focusing on approved or investigational drugs for new indications. Drug repurposing is anticipated to reduce risks and bring drugs to the market in 3-12 years, with an average investment of USD 300 million.

AI accelerates this process by rapidly analyzing extensive biological, chemical, and clinical datasets to identify novel associations between drugs and diseases. This reduces development timelines and costs, offering pharmaceutical companies and healthcare providers an economically viable alternative to the development of new drugs. Integrating artificial intelligence with drug repurposing effectively addresses key industry challenges by enhancing productivity while reducing associated risks and investments. AI enhances this economic advantage by efficiently analyzing extensive chemical libraries, biomedical literature, omics datasets, and real-world evidence to identify a limited set of high-probability candidates, rather than supporting broad empirical screening.

Global Artificial Intelligence In Drug Discovery Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial intelligence in drug discovery market report based on application, therapeutic area, end use, and region.

  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug optimization and repurposing
  • Preclinical testing
  • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68039-029-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Application Segment
    • 1.2.2. Therapeutic Area
    • 1.2.3. End Use
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for cost-effective drug development
      • 3.2.1.2. Increasing clinical trials in drug repurposing
      • 3.2.1.3. Growing focus on precision medicine and targeted drug development
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Highly regulated industry
      • 3.2.2.2. High computational costs and infrastructure requirements
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Study Insights
  • 3.4. Artificial Intelligence in Drug Discovery Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Artificial Intelligence in Drug Discovery Market Application Movement Analysis
  • 4.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 4.4. Drug optimization and repurposing
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Preclinical testing
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Artificial Intelligence in Drug Discovery Market Therapeutic Area Movement Analysis
  • 5.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by Therapeutic Area, 2021 to 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Neurodegenerative Diseases
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Cardiovascular Disease
    • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Metabolic Diseases
    • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.8. Infectious Disease
    • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Artificial Intelligence in Drug Discovery Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Artificial Intelligence in Drug Discovery Market End Use Movement Analysis
  • 6.3. Global Artificial Intelligence in Drug Discovery Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Contract Research Organizations (CROs)
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Academic and Research Institutes
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Other
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2025
  • 8.4. Company Profiles/Listing
    • 8.4.1. Healx
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. BostonGene Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. BenevolentAI
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Innophore
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Delta4.ai
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. BioXcel Therapeutics Inc.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. BullFrog AI Holdings, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Graphwise
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Owkin, Inc
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Insilico Medicine
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. IBM
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Exscientia
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Google (DeepMind)
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. BioSymetrics, Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. BPGbio Inc. (Berg Health)
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Atomwise Inc.
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Product benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Recursion
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Product benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Aitia
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Product benchmarking
      • 8.4.18.4. Strategic initiatives
    • 8.4.19. Insitro
      • 8.4.19.1. Company overview
      • 8.4.19.2. Financial performance
      • 8.4.19.3. Product benchmarking
      • 8.4.19.4. Strategic initiatives
Show more
Product Code: GVR-4-68039-029-7

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Artificial Intelligence In Drug Discovery Market, By Region, 2021 - 2033 (USD Million)
  • Table 3 Global Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 4 Global Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 5 Global Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 North America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 7 North America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 8 North America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 9 North America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 US Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 US Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 12 US Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 15 Canada Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 17 Mexico Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18 Mexico Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 21 Europe Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 22 Europe Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 UK Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 UK Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 25 UK Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 26 Germany Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 27 Germany Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 28 Germany Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 France Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 30 France Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 31 France Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 Italy Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34 Italy Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 35 Spain Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 Spain Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 37 Spain Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 Denmark Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40 Denmark Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 42 Sweden Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 43 Sweden Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Norway Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 46 Norway Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 China Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 China Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 53 China Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Japan Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 Japan Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 56 Japan Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 57 India Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 58 India Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 59 India Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 60 South Korea Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 South Korea Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 62 South Korea Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 63 Australia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 64 Australia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65 Australia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66 Thailand Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 67 Thailand Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 68 Thailand Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69 Latin America Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 71 Latin America Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 72 Latin America Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 73 Brazil Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 Brazil Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75 Brazil Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 76 Argentina Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 77 Argentina Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 78 Argentina Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 MEA Artificial Intelligence In Drug Discovery Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 81 MEA Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 82 MEA Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Africa Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 84 South Africa Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85 South Africa Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 89 UAE Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 UAE Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91 UAE Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Artificial Intelligence In Drug Discovery Market, By Application, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Artificial Intelligence In Drug Discovery Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Artificial Intelligence In Drug Discovery Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Market formulation & validation
  • Fig. 5 Artificial intelligence in drug discovery market: Market outlook
  • Fig. 6 Artificial intelligence in drug discovery market: Segment outlook
  • Fig. 7 Artificial intelligence in drug discovery market: Competitive landscape outlook
  • Fig. 8 Parent market outlook
  • Fig. 9 Artificial intelligence in drug discovery market driver impact
  • Fig. 10 Artificial intelligence in drug discovery market restraint impact
  • Fig. 11 Artificial intelligence in drug discovery market: Application outlook and key takeaways
  • Fig. 12 Artificial intelligence in drug discovery market: Application movement analysis
  • Fig. 13 Drug optimization and repurposing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Preclinical testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Computer vision market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Artificial intelligence in drug discovery market: Therapeutic Area outlook and key takeaways
  • Fig. 18 Artificial intelligence in drug discovery market: Therapeutic Area movement analysis
  • Fig. 19 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Neurodegenerative diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Cardiovascular disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Metabolic diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Infectious disease market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Artificial intelligence in drug discovery market: End use outlook and key takeaways
  • Fig. 26 Artificial intelligence in drug discovery market: End use movement analysis
  • Fig. 27 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Contract research organizations (CROs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Global Artificial intelligence in drug discovery market: Regional outlook and key takeaways
  • Fig. 32 Global Artificial intelligence in drug discovery market: Regional movement analysis
  • Fig. 33 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 US key country dynamics
  • Fig. 35 US market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada key country dynamics
  • Fig. 37 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico key country dynamics
  • Fig. 39 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 UK key country dynamics
  • Fig. 42 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Germany key country dynamics
  • Fig. 44 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 France key country dynamics
  • Fig. 46 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Italy key country dynamics
  • Fig. 48 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Spain key country dynamics
  • Fig. 50 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark key country dynamics
  • Fig. 52 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Sweden key country dynamics
  • Fig. 54 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Norway key country dynamics
  • Fig. 56 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Japan key country dynamics
  • Fig. 59 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand key country dynamics
  • Fig. 65 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 South Korea key country dynamics
  • Fig. 67 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Australia key country dynamics
  • Fig. 69 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Brazil key country dynamics
  • Fig. 72 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Argentina key country dynamics
  • Fig. 74 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 South Africa key country dynamics
  • Fig. 77 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia key country dynamics
  • Fig. 79 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 UAE key country dynamics
  • Fig. 81 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Kuwait key country dynamics
  • Fig. 83 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!